Read on Twitter
Some may say that $FSDC is an undiscovered SPAC. My view is many keeping quiet. Figure sent to me from Nik Tzoumas from "Revisiting ,,,CFH in AMD", CFH mutations in impt complement disorders. Gemini Therapeutics approach is elegant, compelling. Long $FSDC. https://pubmed.ncbi.nlm.nih.gov/33157112/
I will start to lay out my thesis on $FSDC, ie Gemini Therapeutics. My father and I and a brother are in "Beaver Dam Eye Study" out of UW-Madison, Ron and Barbara Klein PIs, 30+ yr ongoing study on AMD. Got me interested then. #CFH biochemistry complex.
But first, further mention of Beaver Dam Eye Study. (No AMD in my lineage, btw) These familial, epidemiological studies (consortia also) are impt for such genetic disease contribution. Two examples cited here. https://pubmed.ncbi.nlm.nih.gov/25905023/
https://pubmed.ncbi.nlm.nih.gov/28108569/
https://pubmed.ncbi.nlm.nih.gov/28108569/
$FSDC Thrilling stock trading ystdy at/after 2 pm. Parking this nice paper on diminished CFH Y402H Bruch's membrane binding. Impt sulfation. Will show cell bio models soon. http://iovs.arvojournals.org/article.aspx?articleid=2129335
